PMID- 30360641 OWN - NLM STAT- MEDLINE DCOM- 20190228 LR - 20190228 IS - 1943-572X (Electronic) IS - 0003-4894 (Linking) VI - 128 IP - 1 DP - 2019 Jan TI - A Critical Reappraisal of Primary and Recurrent Advanced Laryngeal Cancer Staging. PG - 36-43 LID - 10.1177/0003489418806915 [doi] AB - OBJECTIVES: Laryngeal squamous cell carcinoma (LSCC) can involve different anatomic subunits with peculiar surgical and prognostic implications. Despite conflicting outcomes for the same stage of disease, the current staging system considers different lesions in a single cluster. The aim of this study was to critically discuss clinical and pathologic staging of primary and recurrent advanced LSCC in order to define current staging pitfalls that impede a precise and tailored treatment strategy. METHODS: Thirty patients who underwent total laryngectomy in the past 3 years for primary and recurrent advanced squamous cell LSCC were analyzed, comparing endoscopic, imaging, and pathologic findings. Involvement of the different laryngeal subunits, vocal-fold motility, and spreading pattern of the tumor were blindly analyzed. The diagnostic accuracy and differences between clinicoradiologic and pathologic findings were studied with standard statistical analysis. RESULTS: Discordant staging was performed in 10% of patients, and thyroid and arytenoid cartilage were the major diagnostic pitfalls. Microscopic arytenoid involvement was significantly more present in case of vocal-fold fixation ( P = .028). Upstaging was influenced by paraglottic and pre-epiglottic space cancer involvement, posterior commissure, subglottic region, arytenoid cartilage, and penetration of thyroid cartilage; on the contrary, involvement of the inner cortex or extralaryngeal spread tended to be down-staged. Radiation-failed tumors less frequently involved the posterior third of the paraglottic space ( P = .022) and showed a significantly worse pattern of invasion ( P < .001). CONCLUSIONS: Even with the most recent technologies, 1 in 10 patients with advanced LSCC in this case series was differently staged on clinical examination, with cartilage involvement representing the main diagnostic pitfall. FAU - Locatello, Luca Giovanni AU - Locatello LG AUID- ORCID: 0000-0002-1879-5580 AD - 1 Division of Otorhinolaryngology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. FAU - Pietragalla, Michele AU - Pietragalla M AUID- ORCID: 0000-0003-4589-7109 AD - 2 Division of Radiology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. FAU - Taverna, Cecilia AU - Taverna C AD - 3 Institute of Pathology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. FAU - Bonasera, Luigi AU - Bonasera L AD - 2 Division of Radiology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. FAU - Massi, Daniela AU - Massi D AD - 3 Institute of Pathology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. FAU - Mannelli, Giuditta AU - Mannelli G AUID- ORCID: 0000-0001-7079-3964 AD - 1 Division of Otorhinolaryngology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. LA - eng PT - Journal Article DEP - 20181026 PL - United States TA - Ann Otol Rhinol Laryngol JT - The Annals of otology, rhinology, and laryngology JID - 0407300 SB - IM MH - Aged MH - Biopsy/methods/statistics & numerical data MH - *Carcinoma, Squamous Cell/diagnosis/pathology/therapy MH - *Chemoradiotherapy/adverse effects/methods/statistics & numerical data MH - Data Accuracy MH - Female MH - Head and Neck Neoplasms/diagnosis/pathology/therapy MH - Humans MH - Italy MH - *Laryngeal Neoplasms/diagnosis/pathology/therapy MH - *Laryngectomy/adverse effects/methods/statistics & numerical data MH - *Laryngoscopy/methods/statistics & numerical data MH - *Larynx/diagnostic imaging/pathology/physiopathology MH - Male MH - Neoplasm Invasiveness/diagnostic imaging/physiopathology MH - *Neoplasm Recurrence, Local/diagnosis/pathology/therapy MH - *Neoplasm Staging/methods/standards MH - Prognosis MH - Sensitivity and Specificity OTO - NOTNLM OT - TNM OT - cancer staging OT - head and neck cancer OT - laryngeal cancer OT - laryngology EDAT- 2018/10/27 06:00 MHDA- 2019/03/01 06:00 CRDT- 2018/10/27 06:00 PHST- 2018/10/27 06:00 [pubmed] PHST- 2019/03/01 06:00 [medline] PHST- 2018/10/27 06:00 [entrez] AID - 10.1177/0003489418806915 [doi] PST - ppublish SO - Ann Otol Rhinol Laryngol. 2019 Jan;128(1):36-43. doi: 10.1177/0003489418806915. Epub 2018 Oct 26.